Early detection of autoimmune rheumatic diseases is crucial given their high morbidity and mortality and short window of opportunity to improve patient outcomes. Self-administered screening questionnaires such as the connective tissue disease screening questionnaire (CSQ) have been shown to promote early detection of autoimmune rheumatic diseases. However, optimal scoring of screening questionnaires may differ with prevalence of clinical features and changes in classification criteria. We compared the performance of 3 scoring methods for the CSQ for early detection of autoimmune rheumatic diseases in a multi-ethnic Asian population.
Methods
Patients who were newly referred for evaluation of possible autoimmune rheumatic diseases were invited to answer the cross-culturally adapted CSQ. Detection of autoimmune rheumatic diseases using 1) the original CSQ scoring, 2) a modified CSQ scoring and 3) a scoring based on current classification criteria, were compared to classification of autoimmune rheumatic diseases by classification criteria.
Results
Of 819 participants, 85 were classified as having autoimmune rheumatic diseases screened for by the adapted CSQ. The original CSQ scoring yielded relatively lower sensitivities in detecting both any and individual autoimmune rheumatic diseases (67% and 20-57%, respectively) compared to the modified CSQ scoring (81% and 60-73%, respectively) and the scoring based on current classification criteria (89% and 50-88%, respectively).
Conclusion
The adapted CSQ with the classification criteria-based scoring achieved relatively high sensitivities in detecting autoimmune rheumatic diseases, suggesting this could be employed as the first step in population screening.
VosTFlaxmanADNaghaviM, et al.
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet2012;
380: 2163–2196.
2.
Epidemiology & Disease Control Division Ministry of Health Singapore. Singapore burden of disease study 2010.
Singapore:
Ministry of Health Singapore, 2014.
3.
van NiesJAKrabbenASchoonesJWHuizingaTWKloppenburgMvan der Helm-van MilAH.What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis2014;
73: 861–870.
4.
RobinsonPCBrownMA.The window of opportunity: a relevant concept for axial spondyloarthritis. Arthritis Res Ther2014;
16: 109.
5.
AndersonJJWellsGVerhoevenACFelsonDT.Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum2000;
43: 22–29.
6.
BreedveldF.The value of early intervention in RA – a window of opportunity. Clin Rheumatol2011;
30(Suppl 1): S33–S39.
7.
FinckhALiangMHvan HerckenrodeCMde PabloP.Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum2006;
55: 864–872.
8.
NellVPMacholdKPEberlGStammTAUffmannMSmolenJS.Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford, England.)2004;
43: 906–914.
9.
Hernandez-GarciaCVargasEAbasoloL, et al.
Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol2000;
27: 2323–2328.
10.
KumarKDaleyECarruthersDM, et al.
Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford)2007;
46: 1438–1440.
11.
De CockDMeyfroidtSJolyJVan der ElstKWesthovensRVerschuerenP; on behalf of the CareRA study group.A detailed analysis of treatment delay from the onset of symptoms in early rheumatoid arthritis patients. Scand J Rheumatol2014;
43: 1–8.
12.
VilleneuveENamJLBellMJ, et al.
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis. Ann Rheum Dis2013;
72: 13–22.
13.
LeeHSOhKTKimTHJungSYooDHBaeSC.A Korean rheumatic diseases screening questionnaire. J Korean Med Sci2003;
18: 171–178.
14.
RichterJGWesselEKlimtRWillersRSchneiderM.RheumaCheck: development and evaluation of a German language screening instrument for rheumatic diseases. Wien Klin Wochenschr2008;
120: 103–111.
15.
DeaneKDStriebichCCGoldsteinBL, et al.
Identification of undiagnosed inflammatory arthritis in a community health fair screen. Arthritis Rheum2009;
61: 1642–1649.
16.
HeinertJIking-KonertCBlumenrothMSanderORichterJSchneiderM.Novel approach for the early detection of inflammatory rheumatic diseases in the population using a mobile screening unit. Z Rheumatol2010;
69: 743–748.
17.
LiRSunJRenLM, et al.
Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford)2012;
51: 721–729.
18.
KarlsonEWSanchez-GuerreroJWrightEA, et al.
A connective tissue disease screening questionnaire for population studies. Ann Epidemiol1995;
5: 297–302.
19.
AletahaDNeogiTSilmanAJ, et al.
2010 Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum2010;
62: 2569–2581.
20.
PetriMOrbaiAMAlarconGS, et al.
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheumat2012;
64: 2677–2686.
21.
van den HoogenFKhannaDFransenJ, et al.
2013 Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum2013;
65: 2737–2747.
22.
ShiboskiCHShiboskiSCSerorR, et al.; International Sjögren's Syndrome Criteria Working Group.
2016 American college of rheumatology/European league against rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol (Hoboken, NJ)2017;
69: 35–45.
23.
LundbergIETjarnlundABottaiM, et al.; the International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland).
European league against rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol2017;
69: 2271–2282.
24.
XiangLTeoEPSLowAHL, et al.
Cross-cultural adaptation of the connective tissue disease screening questionnaire and development of a Chinese version in a multi-ethnic Asian population. Clin Rheumatol2019;
38: 2383–2397.
25.
GonzalezLATolozaSMMcGwinGJrAlarconGS.Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. Lupus2013;
22: 1214–1224.
26.
MokMYLiWL.Do Asian patients have worse lupus?Lupus2010;
19: 1384–1390.
27.
LauCSYinGMokMY.Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus2006;
15: 715–719.
28.
MokCCLauCS.Lupus in Hong Kong Chinese. Lupus2003;
12: 717–722.
29.
ThumbooJUramotoKO'FallonWM, et al.
A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum2001;
45: 494–500.
30.
WangFWangCLTanCTManivasagarM.Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus1997;
6: 248–253.
31.
SamantaAFeehallyJRoySNicholFESheldonPJWallsJ.High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis1991;
50: 490–492.
Alarcon-SegoviaDVillarealM.Classification and diagnostic criteria for mixed connective tissue disease. In: KasukawaRSharpGC (eds) Mixed connective tissue disease and anti-nuclear antibodies.
Amsterdam:
Elsevier, 1987, p.33.
34.
TaylorWGladmanDHelliwellPMarchesoniAMeasePMielantsH; CASPAR Study Group.Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum2006;
54: 2665–2673.
35.
GuernePAWeismanMH.Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am J Med1992;
93: 451–460.
36.
MoscaMNeriRBombardieriS.Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol1999;
17: 615–620.
37.
ArnettFCEdworthySMBlochDA, et al.
The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988;
31: 315–324.
38.
TanEMCohenASFriesJF, et al.
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982;
25: 1271–1277.
39.
MasiAT, Diagnostic SFSCotARA and Committee TC; Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthritis Rheum1980;
23: 581–590.
40.
BohanAPeterJB.Polymyositis and dermatomyositis (first of two parts). N Engl J Med1975;
292: 344–347.
41.
FoxRIRobinsonCCurdJMichelsonPBoneRHowellFV.First international symposium on Sjogren's syndrome: suggested criteria for classification. Scand J Rheumatol Suppl1986;
61: 28–30.
42.
MaricqHRWeinrichMC.Diagnosis of Raynaud's phenomenon assisted by color charts. J Rheumatol1988;
15: 454–459.
43.
BrennanPSilmanABlackC, et al.
Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK scleroderma study group. Br J Rheumatol1993;
32: 357–361.
44.
HwangAGuptaSLiangMH.Identification of people with very early RA for optimal care: a public health challenge. Nat Clin Pract Rheumatol2008;
4: 114–115.
45.
LiangMHMeenanRFCathcartESSchurPH.A screening strategy for population studies in systemic lupus erythematosus. Series design. Arthritis Rheum1980;
23: 153–157.
46.
KarlsonEWCostenbaderKHMcAlindonTEMassarottiEM, et al.
High sensitivity, specificity and predictive value of the connective tissue disease screening questionnaire among urban African-American women. Lupus2005;
14: 832–836.
47.
AringerMCostenbaderKDaikhD, et al.
2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis2019;
78: 1151–1159.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
